Valuation: Convatec Group PLC

Market Cap 6.35B 5.69B 5.25B 4.75B 8.88B 604B 9.02B 62.58B 24.97B 316B 23.82B 23.32B 1,002B P/E 2026 *
25x
P/E 2027 * 17.2x
Enterprise Value 7.75B 6.94B 6.4B 5.79B 10.84B 738B 11.01B 76.4B 30.48B 386B 29.08B 28.46B 1,223B EV / Sales 2026 *
3.03x
EV / Sales 2027 * 2.77x
Free-Float
95.08%
Yield 2026 *
2.46%
Yield 2027 * 2.81%
1 day+0.17%
1 week+0.25%
Current month+14.73%
1 month+13.93%
3 months+6.18%
6 months+15.85%
Current year+0.25%
1 week 12.97
Extreme 12.97
13.55
1 month 11.31
Extreme 11.31
13.55
Current year 10.45
Extreme 10.45
14.09
1 year 10.45
Extreme 10.45
14.09
3 years 9.9
Extreme 9.9
16.65
5 years 8.69
Extreme 8.69
16.65
10 years 0
Extreme 0
18.52
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%+0.25% - - 6.35B
+0.87%+0.98%-16.81%+11.30% 178B
+2.34%+1.24%-15.88%+18.40% 117B
+2.23%+0.31%+5.63%+38.47% 116B
+0.28%+0.59%-44.02%+5.89% 91.03B
+0.97%-3.21%-1.67%+76.70% 61.89B
-0.32%-0.66%+10.51%+81.65% 55.85B
+0.45%-2.30%+7.88%-22.01% 53.16B
+1.79%+1.18%-8.64%+44.66% 44.35B
+1.94%+1.59%-1.11%-6.97% 33.59B
Average +1.07%+0.95%-7.12%+27.57% 83.34B
Weighted average by Cap. +1.22%+1.25%-10.28%+25.38%

Financials

2026 *2027 *
Net sales 2.55B 2.29B 2.11B 1.91B 3.57B 243B 3.63B 25.17B 10.04B 127B 9.58B 9.38B 403B 2.73B 2.45B 2.26B 2.04B 3.82B 260B 3.88B 26.94B 10.75B 136B 10.26B 10.04B 431B
Net income 250M 224M 207M 187M 350M 23.85B 356M 2.47B 985M 12.48B 940M 920M 39.53B 364M 326M 301M 272M 510M 34.7B 518M 3.59B 1.43B 18.16B 1.37B 1.34B 57.52B
Net Debt 1.4B 1.26B 1.16B 1.05B 1.96B 133B 1.99B 13.82B 5.51B 69.85B 5.26B 5.15B 221B 1.22B 1.1B 1.01B 915M 1.71B 117B 1.74B 12.06B 4.81B 60.97B 4.59B 4.49B 193B
Projected Income Statement - Annual - Convatec Group PLC
Logo Convatec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
Date Price Change Volume
30/10/26 USD 13.10 +0.17% 4,447
28/10/26 USD 13.08 -0.30% 6,895
27/10/26 USD 13.12 +0.15% 15,925
26/10/26 USD 13.10 -1.36% 76,468
23/10/26 USD 13.28 +1.61% 18,561
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Convatec Group PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
3.248USD
Average target price
4.022USD
Spread / Average Target
+23.82%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Convatec Group PLC